Page 6 | Certara

Case Study

Discover how Certara's partnership with TrialAssure provides global sponsors with accelerated, compliant, and enhanced document…

CertaraOctober 3, 2025

Case Study

Certara’s support enabled fast-track FDA oncology approval 2025 for Sunvozertinib, a breakthrough NSCLC therapy targeting…

CertaraOctober 2, 2025

Press Coverage Video

Ananth Kadambi outlines how clinical operations teams can plan for FDA’s OS requirements—enhancing patient tracking…

CertaraSeptember 26, 2025

Press Coverage Video

Discover how real-world evidence and predictive modeling strengthen OS-focused trial designs in oncology, improving efficiency…

CertaraSeptember 25, 2025

Press Coverage Video

Ananth Kadambi shares how model-informed drug development helps sponsors predict efficacy and align shorter oncology…

CertaraSeptember 24, 2025

Press Coverage Video

Ananth Kadambi explains how FDA’s emphasis on overall survival reshapes oncology drug trial success metrics…

CertaraSeptember 23, 2025

Conference

On-Demand Webinar

CertaraSeptember 22, 2025